[1] Martha RH.Autsm:a brain disorder,or a disorder that affects the brain?[J].Clinical Neuropsychiatry,2005,2(6):354-379.
[2] James JB,Scott S,Matthew B,et al.Biomarker-guided interventions of clinically relevant conditions associated with autism sprctrum disorders and attention deficit hyperactivity disorder[J].Alternative Medicine Review.2011,15(1):15-32.
[3] Carr EG,Owen-DeSchryver JS.Physical illness,pain,and problem behavior in minimally verbal people with developmental disabilities[J].Journal of Autism and Developmental Disorders,2007,37(3):413 -424.
[4] Geier DA,Geier MR.A rospective assessment of porphyrins in autistic disorders:a potential marker for heavy metal exposure[J].Neurotoxicity Research,2006,10:57-64.
[5] Croonenberghs J,Wauters A,Deboune D,et al.Central serotonergic hypofunction in autism:results of the 5-hydroxy-tryptophan challenge test[J].Neuroendocrinology Letters,2007,28:449-455.
[6] Polleux F,Lauder JM.Toward a developmental neurobiology of autsm[J].Mental Retardation and Developmental Disabilities Research Reviews,2004,10:303-317.
[7] Belmonte MK,Cook EH,Jr Anderson,et al.Autism as a disorder of neural information processing:directions for research and targets for therapy[J].Molecular Psychiatry,2004,9:646-663.
[8] Geier DA,Kern JK,Garver CR,et al.Biomarkers of environmental toxicity and susceptibility in autism[J].Journal of the Neurological Sciences,2009,280:101-108.
[9] James SJ,Cutler P,Melnyk S,et al.Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism[J].American Journal of Clinical Nutrition,2004,80:1611-1617.
[10] Blaylock PL,Strunecka A.Immune-glutamatergic dysfunction as a central mechanism of the autism spectrum disorders[J].Current Medicinal Chemistry,2009,16:157-170.
[11] Geier DA,Sykes LK,Geier MR.A review of Thimerosal (Merthiolate) and its ethylmercury breakdown product:specific historical considerations regarding safety and effectiveness[J].Journal of Toxicology and Environmental Health Part B:Critical Reviews,2007,10:575-596.
[12] Ivan KS,Yap MA.Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls[J].Journal of Proteome Research,2010,9:2996-3004.
[13] Cecilia G,Zhang YF,Alicja OK,et al.Mitochondrial dysfunction in autism[J].Journal of American Medical Association,2010,304(21):2389-2396.
[14] Knickmeyer RC,wheelwright S,Baron-Cohen SB.Sex-typical play:masculinization/defeminization in girls with an autism spectrum condition[J].Journal of Autism and Developmental Disorders,2008,38:1028-1035.
[15] Evans C,Dunstan RH,Rothkirch T,et al.Altered amino acid excretion in children with autism[J].Nutritional Neuroscience,2008,11:9-17.
[16] Filipek PA,Juranek J,Nguyen MT,et al.Relative carnitine deficinency in autism[J].Journal of Autism Development Disorder,2004,34:615-623.
[17] Hara H.Autism and epilepsy:a retrospective follow-up study[J].Brain Development,2007,29(8):486-490.
[18] Balmiki R,Justin ML,Deborah KS.Increased secreted amyloid precursor protein-a (sAPPa) in severe autism:proposal of a specific,anabolic pathway and putative biomarker[J].Plos One,2011,6(6):e20405:1-10.
[19] Chauhan A,Chauhan V.Oxidative stress in autism[J].Pathophysiology,2006,13:171-181.
[20] Timothy B,Daniel BC.Evaluation,diagnosis,and treatment of gastrointestinal disorders in individuals with ASDs:A consensus report[J].Pediatrics,2010,125(S):1- 18.
[21] Hashimoto K,Lwata Y,Nakamura K,et al.Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism[J].Progress in Neuro-Psychopharmacology & Biological Psychiatry,2006,30:1529-1531.
[22] Galli-Carminati G,Deriaz N,Bertschy G.Melationin in treatment of chronic sleep disorders in adults with autism:a retrospective study[J].Swiss Medical Weekly,2009,139:293-296.
[23] Massimo C,Irene M,Rosanna I,et al.Hypo-phosphorylation of salivary peptidome as a clue to the molecular pathogenesis of autism spectrum disorders[J].Journal of Proteome Research,2008,7:5327-5332.